Skip to main content
. 2025 Jan 7;28(2):111768. doi: 10.1016/j.isci.2025.111768

Table 1.

Clinical information

Number Gender Age Stage 18.2 express Dose PFS (d) OS (d) Clinical evaluation Peritoneal dropsy
Case1 Female 63 pT4aN0 2+, 80% 2.5∗108 58 85 PD PD’
Case2 Male 45 pT4aN3bM1 2+, 70% 2.5∗108 143 143 PD PD’
Case3 Male 59 cTxNxM1 3+, 90% 2.5∗108 78 91 PD PR’
Case4 Female 57 cT4aN2M1 3+, 90% 2.5∗108 54 140 PD PR’
Case5 Female 31 pT3N1 3+, 90% 2.5∗108 596 680 PR PR’

PFS, progression-free survival; OS: overall survival; PD, progressive disease; PR, partial response.